2016newlogowords
AACT August Section Webinar: Opioid or not – the relevance of Kratom in the context of the opioid crisis Enduring
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
Was the educational content of value to you?
Was the educational content scientifically sound?
If no, please explain...
Did you perceive any commercial bias or influence in the educational content?
If yes, please explain...
Did this activity improve your Skills or Strategy?
If yes, how...
Do you think what you learned will benefit you in your practice?
If yes, how...
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
What questions are you having in your practice that you would like to see addressed in an educational activity?
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924: 
Please rate Oliver Grundmann
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Were the learning objectives met?
Critically evaluate the impact of kratom use among the general population and those with a substance use disorder.
Justify a differential approach to treatment for kratom use disorder opposed to opioid use disorder.
Summarize the potential does-dependent adverse and toxic effects of kratom use a well as drug interaction pertinent to clinical practice.
When you viewed this webinar, were you in a group or by yourself?
If in a group, with how many people?
Comments:
Mr question
Provided by amedco